Skip to main content
123 Results For "leishmaniasis"
 
msf-placeholder
Sudan

Deadly kala azar threatens thousands in exhausted southern Sudan

"The state of these patients is appalling. They are being carried on stretchers for days to make it to the clinic. They look pale and thin and are extremely anaemic," said Dr. José-Antonio Bastos, an MSF Operational Director. Press Release - 8 Nov 2002
 
msf-placeholder
Access to medicines

US trade position threatens access to medicines in Latin America and the Caribbean

Trade objectives proposed by the United States are threatening access to affordable lifesaving medicines for people with HIV/AIDS and other diseases in Latin America and the Caribbean, according to Medecins Sans Frontieres (MSF). Press Release - 31 Oct 2002
 
msf-placeholder
Neglected diseases

Reflection and Reaction: Drugs for neglected diseases

Sleeping sickness drugs were developed during colonial times. Malaria causes over two million deaths every year, yet antimalarial drugs were made primarily for the colonial administration, western tourists, and the military. Project Update - 27 Jul 2002
 
msf-placeholder
Neglected diseases

The Lancet: Drugs for neglected diseases

Lack of scientific knowledge is not the major barrier to drug development. Selection is based on potential profits, not global public health concerns. This system obviously fails the needs of poor countries. Project Update - 1 Jul 2002
 
msf-placeholder
Access to medicines

Photo exhibition: Too poor to be treated

Thanks to medical advances and improved living conditions, life expectancy in wealthy countries increases by four months every year. But in poor countries, treatment for certain life-threatening diseases is not available to those who need it. Project Update - 21 Jun 2002
 
msf-placeholder
Neglected diseases

New drug for visceral leishmaniasis is first step in tackling neglected diseases - but much more must be done

MSF welcomes this week's news from the World Health organization that miltefosine, a new drug to treat visceral leishmaniasis*, has been registered in India and can now be used to treat patients infected with this killer disease. Press Release - 21 Jun 2002
 
msf-placeholder
Global health

Brundtland sets out priorities at annual World Health Assembly

Meanwhile MSF called on WHO to show greater courage against the pharmaceutical giants. Project Update - 18 May 2002
 
msf-placeholder
Access to medicines

Fighting the 10/90 gap

Less than 10% of the worldwide expenditure on health research and development is devoted to the major health problems of 90% of the population. The MSF initiative targets the most neglected diseases; how scientists can help. Project Update - 13 May 2002
 
msf-placeholder
Access to medicines

MSF recommendations to the 55th meeting of the WHA

From May 13-18, the World Health Assembly (WHA) is meeting to debate and set policy for the WHO. MSF provides the following recommendations regarding access to essential medicines. Project Update - 13 May 2002
 
msf-placeholder
DNDi

DND Conference review

DND Conference: The Crisis of Neglected Diseases: Developing Treatments and Ensuring Access. March 12-14, 2002 Workshop and Conference, New York City Project Update - 8 Apr 2002
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more